Pages that link to "Q44675420"
Jump to navigation
Jump to search
The following pages link to Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. (Q44675420):
Displaying 50 items.
- Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination (Q26765345) (← links)
- Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer (Q28066486) (← links)
- Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets (Q28076161) (← links)
- Myeloid-derived suppressor cells as regulators of the immune system (Q28131637) (← links)
- Myeloid-derived cells are key targets of tumor immunotherapy (Q28388246) (← links)
- Coordinated regulation of myeloid cells by tumours (Q28395157) (← links)
- The role of myeloid-derived suppressor cells in immune ontogeny (Q28654584) (← links)
- Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity (Q33598739) (← links)
- Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer (Q33606107) (← links)
- The vitamin D connection to pediatric infections and immune function (Q34078700) (← links)
- Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling (Q34079557) (← links)
- Targeting immune suppressing myeloid-derived suppressor cells in oncology. (Q34082067) (← links)
- All-trans retinoic acid in combination with primaquine clears pneumocystis infection (Q34545112) (← links)
- Molecular pathways: myeloid complicity in cancer (Q34725969) (← links)
- Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. (Q35036628) (← links)
- The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity (Q35675017) (← links)
- Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Q35915614) (← links)
- 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells (Q35915769) (← links)
- Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck (Q35922983) (← links)
- Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis (Q36102797) (← links)
- Role of immature myeloid cells in mechanisms of immune evasion in cancer (Q36208862) (← links)
- Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. (Q36249153) (← links)
- Protective mechanisms of head and neck squamous cell carcinomas from immune assault (Q36311985) (← links)
- Myeloid derived suppressor cells in human diseases (Q36338349) (← links)
- Toward a core nutraceutical program for cancer management (Q36473648) (← links)
- Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction (Q36476085) (← links)
- Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia (Q36644639) (← links)
- Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer (Q36896764) (← links)
- Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. (Q37017190) (← links)
- Myeloid-derived suppressor cells: natural regulators for transplant tolerance (Q37019136) (← links)
- Immune-checkpoint blockade and active immunotherapy for glioma (Q37420586) (← links)
- Myeloid-Derived Suppressor Cells in Human Cancer (Q37778697) (← links)
- Camouflage and sabotage: tumor escape from the immune system (Q37882478) (← links)
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients (Q37961577) (← links)
- Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention (Q38016208) (← links)
- Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. (Q38154151) (← links)
- Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer (Q38165930) (← links)
- Inflammation and pancreatic cancer: disease promoter and new therapeutic target (Q38167608) (← links)
- Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets (Q38269370) (← links)
- Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer (Q38528814) (← links)
- The immunobiology of myeloid-derived suppressor cells in cancer (Q38649547) (← links)
- Myeloid-derived suppressor cells: The green light for myeloma immune escape. (Q38821941) (← links)
- On the origin of myeloid-derived suppressor cells. (Q38968944) (← links)
- The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients. (Q38971075) (← links)
- The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment (Q39478416) (← links)
- Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer (Q41110098) (← links)
- Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas (Q46743215) (← links)
- Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives (Q47651773) (← links)
- Targeting Myeloid-Derived Suppressor Cells in Cancer (Q47765346) (← links)
- CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D. (Q52677584) (← links)